Guidelines & Advice

Treatment

Treatment is determined by the type and stage of cancer, as well as by what treatments and services a patient chooses. The guidelines and other documents available here focus on topics related to the treatment of cancer in Ontario.

Multidisciplinary Cancer Conferences

Displaying Guidelines

361 Items

Imatinib Mesylate (Gleevec™) for the Treatment of Adult Patients with Unresectable or Metastatic Gastrointestinal Stromal Tumours

Document Status: Archived
ID: 11-7
Version: 3

May 2015

Imatinib Mesylate in the Adjuvant Treatment of Gastrointestinal Stromal Tumours (GIST)

Document Status: Archived
ID: CED 17

Mar 2010

Immune Checkpoint Inhibitor Toxicity Management Clinical Practice Guideline

Document Status: Current
Version: 1

Mar 2018

Implementation Strategy for Radiation Therapy Safety Straps

Document Status: Current
ID: GL-C50-22

Oct 2015

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Document Status: Current
ID: GL 17-12
Version: N/A

Sep 2019

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Document Status: In-Review
ID: 7-13

Oct 2017

Interferon-alfa in the Treatment of Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer

Document Status: Archived
ID: 3-8-1

Apr 2013

Interleukin-2 in the Treatment of Patients with Unresectable or Metastatic Renal Cell Cancer

Document Status: Archived
ID: 3-8-2
Version: 2

Sep 2011

Interventions to Address Sexual Problems in People with Cancer

Document Status: In-Review
ID: 19-6

Apr 2016

Iodine-131 Tositumomab in Lymphoma

Document Status: Archived
ID: 6-19

Jan 2007

Kadcyla® Trastuzumab Emtansine Safety Reminder

Document Status: Current
ID: GL-C50-15

Jun 2014

Laparoscopic Surgery for Cancer of the Colon

Document Status: Archived
ID: 2-20-2

Sep 2005